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Abstract The aim of the present study was to assess the
effect of quercetin and imperatorin administered separately
and in combination on apoptosis and autophagy induction
in human cervical carcinoma HeLa cells and laryngeal
carcinoma Hep-2 cells cultured in vitro. Conducted MTT
measurements proved that quercetin and imperatorin dis-
played a strong antiproliferative activity manifested in
markedly reduction of HeLa and Hep-2 cells viability as a
result of treatment with 50 lM of each compound. Further
cell staining assays revealed that concentration mentioned
above generated the highest percentage of apoptotic cells
especially in the case of application of both drugs for 48 h.
Simultaneous quercetin and imperatorin administration
induced apoptosis remarkably stronger than treatment with
single drugs. Experiments at the molecular level confirmed
these results accompanied with the decreased Hsp27 and
Hsp72 expression and, in addition, with increased caspases
activity. Autophagy was not observed and no significant
changes in the expression of beclin-1 were noticed. Addi-
tionally, experiments were performed on the above-men-
tioned cell lines with blocked Hsp27 and Hsp72
expression. In these cells, no significant changes in the
sensitivity to apoptosis induction upon quercetin and im-
peratorin treatment were observed. The present study has
provided evidence supporting the potential of the combi-
nation of quercetin and imperatorin drugs as a novel tool to
be used in anticancer therapy. Our results have also dem-
onstrated that blocking of the Hsp27 and Hsp72 gene
expression is not enough to sensitize cancer cells to pro-
grammed cell death induction in HeLa and Hep-2 cells.
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Introduction
In the past decade, the strategy for killing cancer cells
through programmed cell death (apoptosis, autophagy) has
been extensively studied. Literature data indicate a number
of details concerning the regulation of both apoptosis and
autophagy. Manipulation of these processes, as well as
precise control of their pace and intensity may lead to the
desired destination, being one of the strategies in the fight
against cancer.
Apoptosis, also known as type I programmed cell death,
is an essential physiological process playing a crucial role
in tissue development and homeostasis. To date, research
indicates that apoptotic signals may proceed through two
main pathways, intrinsic (mitochondrial) related to cyto-
chrome c release into the cytosol and extrinsic associated
with the activation of death receptors. However, regardless
of the type of apoptosis, both pathways lead to activation of
caspases [1–5]. In turn, autophagy, i.e., type II programmed
cell death, is a phylogenetically old process used as a tool
not only for death but also for survival. Autophagy is
known as an intracellular system of degradation of cyto-
plasm components in particular long-half-life proteins
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through lysosomal enzymes. The outcome of autophagy is
always the same—total and irreversible dismantling of
macromolecular substrates to their basic components [6–9].
Heat shock proteins have become the oldest cell pro-
tecting system; also called molecular chaperones, they are
important effectors of cellular stress response. The scope of
Hsps duties includes involvement in assistance with the
native protein folding, maintenance of the proper confor-
mation of multiprotein complexes, and degradation of
senescent proteins in a situation where repair is not pos-
sible [10–12]. One of the best-studied proteins are Hsp27
and Hsp72, the most strongly and universally synthesized
chaperones. Hsp27 and Hsp72 inhibit key effectors of the
apoptotic machinery; therefore, accumulation of these
proteins in the cell is an important cytoprotective factor
allowing survival in adverse conditions not only in normal
cells. Numerous investigations indicate overexpression of
Hsp27 and Hsp72 observed in many types of cancer; hence,
it is believed that they stimulate the process of carcino-
genesis [13–15].
One of the well-known Hsps inhibitors is quercetin
(3,30,40,5-7-pentahydroxyflavone), one of the best-descri-
bed flavonoid. Quercetin, widely distributed in the plant
kingdom, has become an ingredient of most daily-con-
sumed fruit and vegetables. Like many compounds of this
group, it has strong antioxidant, antiinflammatory, and
antiproliferative properties. Recently quercetin has gained
special attention as a potential anticancer agent inducing
apoptosis in numerous types of cancer [16–20]. The
mechanism of this reaction is based on inhibiting the
activity of DNA topoisomerase I/II, modulation of signal-
ing pathways, release of cytochrome c, and activation of
caspases [21, 22].
Imperatorin (8-isopentenyloxypsoralen), a major active
furanocoumarin isolated from the root of Angelica offici-
nalis, has been reported to possess a wide range of bio-
logical activities including analgesic, antiinflammatory,
anticoagulant, and photosensitizing properties. Recent
reports have shown pharmacological actions of imperatorin
against cancer manifested in suppression of oncogenes,
inhibition of proliferation, arresting the cell cycle in the
G1/S phase, and induction of apoptosis in several types of
cancer [23–27].
Therefore, the aim of the present study was to examine
the effect of quercetin and imperatorin administered sep-
arately or in combination on programmed cell death
induction (apoptosis and autophagy) in the human cervical
carcinoma HeLa and laryngeal carcinoma Hep-2 cell lines
cultured in vitro. In order to determine the pathways
through which apoptosis and autophagy take place in cell
lines studied, we investigated the expression of marker
proteins involved in these processes at the molecular level.
We also assessed the potential of Hsp27 and Hsp72
expression in protecting cancer cells from cell death
induction.
Materials and methods
Cells and culture conditions
The human cervical carcinoma cells (HeLa) and laryngeal
carcinoma cells (Hep-2) were grown in a 1:1 mixture of
DMEM and Nutrient mixture F-12 Ham (Ham’s F-12,
Sigma) supplemented with 10 % FBS (Life Technologies,
Karlsruhe, Germany), penicillin (100 lg/ml, Sigma), and
streptomycin (100 lg/ml, Sigma). The cultures were kept
at 37 C in humidified atmosphere of 95 % air and 5 %
CO2.
Imperatorin isolation
Imperatorin was isolated from the fruits of A. officinalis in
the Department of Pharmacognosy, Medical University of
Lublin, Poland. The air-dried and powdered fruits of
A. officinalis were extracted with petroleum ether exhaus-
tively in the Soxhlet apparatus, which yielded a fraction of
furanocoumarins obtained as a semi-crystalline sediment
from the concentrated extract. Then, the imperatorin-rich
sediment obtained from the fruits of A. officinalis was first
dissolved in hot dichloromethane, and then subjected to
crystallization with cold n-hexane. The sediment formed
was recrystallized three times in methanol, which led to
isolation of imperatorin. The identity and purity of impe-
ratorin were confirmed by HPLC and H-NMR analyses
[28].
Drug treatment
Quercetin (Sigma) at the final concentrations 50 and
100 lM and imperatorin at the final concentrations 50 and
100 lM were used in the experiments. The drugs were
dissolved in dimethyl sulfoxide (DMSO, Sigma). The final
concentration of DMSO in the culture medium did not
exceed 0.01 %, which as indicated in preliminary experi-
ments, did not influence cell viability and the expression of
the proteins studied. Three variants of drug treatment were
performed. In the first one, HeLa and Hep-2 cells were
incubated only with quercetin or only with imperatorin for
24 and 48 h. In the second, quercetin and imperatorin were
added to the culture medium at the same time and incu-
bated for 24 and 48 h. In the third variant, the cells were
pre-incubated with quercetin or imperatorin for 6 or 24 h
followed by the administration of the other compound and
incubated for the next 18 or 24 h. Control cells were
incubated with 0.01 % of DMSO.
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MTT assay
To determine HeLa and Hep-2 cells viability upon quer-
cetin and imperatorin treatment the colometric MTT (3-
(4,5-dimethylthiazole-2-yl)-2,5-diphenyltetrazolium bro-
mide) metabolic activity assay was used. HeLa and Hep-2
cells grown in 96-well multiplates in 100 ll of culture
medium supplemented with 2 % FBS were incubated for
3 h with MTT solution (5 mg/ml, 25 ll/well) (Sigma). The
yellow tetrazolium salt was metabolized by viable cells to
purple crystals of formazan. The crystals were next solu-
bilized overnight in a mixture consisting of 10 % SDS
(Sigma) in 0.01 M HCl. The final product of cell metab-
olism was quantified spectrophotometrically by absorbance
measurement at 570 nm wavelength using an E-max
Microplate Reader (Molecular Devices Corporation, Menlo
Park, CA, USA).
Detection of apoptosis and necrosis with fluorochromes
For identification of apoptosis and necrosis, the HeLa and
Hep-2 cells were stained with a mixture of fluorescent dyes
Hoechst 33342 (Sigma) and propidium iodide (PI) (Sigma),
respectively [29]. The staining mixture was added in a
volume of 2.5 ll/ml to the medium in which the cells were
grown and incubated for 5 min at 37 C in the dark.
Apoptotic and necrotic cells were visualized and scored (at
least 1,000 cells from randomly selected fields) under a
fluorescent microscope (Nikon E800). Cells undergoing
apoptosis demonstrated blue fluorescent nuclei (intact or
fragmented) as a result of staining with Hoechst 33342. In
turn cells stained with PI and exhibiting pink fluorescent
nuclei were interpreted as necrotic. Three independent
experiments were performed.
Detection of autophagy with acridine orange
Autophagy is a process that involves sequestration and
delivery of cytostolic components to the lysosome for
degradation; it is characterized by formation and promotion
of acidic vesicular organelles (AVOs). Vital staining with
acridine orange was performed for identification of AVOs
in HeLa and Hep-2 cells treated with quercetin and/or
imperatorin [30]. The cells were incubated with the fluo-
rochrome at a final concentration 1 lg/ml for 15 min in the
dark. Autophagic positive cells demonstrated typical
granular discretion of AVOs in the cytoplasm. Morpho-
logical analysis was performed under a fluorescent micro-
scope (Nikon E800). Autophagic cells were visualized and
counted (at least 1,000 cells from randomly selected fields).
Three independent experiments were performed. The per-
centage of autophagic cells was calculated as the number of
cells with AVOs versus the total number of stained cells.
Each experiment was performed in triplicate.
Immunoblotting technique
After the quercetin and/or imperatorin treatment, the HeLa
and Hep-2 cells were lysed in hot SDS-loading buffer
(125 mM Tris–HCl, pH 6.8; 4 % SDS; 10 % glycerol;
100 mM DTT), boiled in a water bath for 10 min, centri-
fuged at 10,0009g at 4 C for 10 min, and the supernatants
were collected. The Bradford method was used to deter-
mine the concentration of protein in the cell-free extracts
obtained [31]. Samples of supernatants containing 80 lg of
proteins were separated by 10 % SDS–polyacrylamide gel
electrophoresis [32], and subsequently transferred onto the
Immobilon P membrane (Millipore). Following the trans-
fer, non-specific binding sites on the membrane were
blocked with 3 % low fat milk in PBS for 1 h and incu-
bated overnight with rabbit polyclonal anti-beclin-1 anti-
body (Sigma) diluted 1:1,000, goat anti-Hsp27 monoclonal
antibody (Santa Cruz Biotechnology) diluted 1:1,000, and
anti-Hsp72 (Santa Cruz Biotechnology) diluted 1:1,000.
After the incubation, the membranes were washed three
times for 10 min with PBS containing 0.05 % Triton
X-100 (Sigma) and incubated for 2 h with a 1:30,000
dilution of alkaline phosphatase-conjugated anti-rabbit IgG
or anti-goat IgG (Sigma). The membranes were visualized
by the colorimetric reaction with alkaline phosphatase
substrate (5-bromo-4-chloro-3-indolylphosphate and nitro-
blue tetrazolium, Sigma) in a color development buffer
(DMF, Sigma). Quantitative evaluation of the expression of
heat shock proteins with molecular weights of 27 and
72 kDa and beclin-1 was determined using the Bio-Profil
Bio-1D Windows Application V.99.03 program. Three
independent experiments were performed.
Blocking of the expression of Hsp27 and Hsp72
in HeLa and Hep-2 cells
To block the expression of Hsp27 and Hsp72, transfection of
HeLa and Hep-2 cells with specific, commercially available
siRNAs (Santa Cruz Biotechnology) was performed
according to the manufacturer’s protocol. The amounts of
specific siRNA and Transfection Reagent were selected
experimentally. Our investigations revealed that when the
quantity of each component exceeded 4 ll it was cytotoxic
to HeLa and Hep-2 cell lines. The blocking procedure was
performed in 6-well tissue culture plates at cell density of
2 9 105. Prior to transfection, a mixture containing specific
siRNA (4 ll) and Transfection Reagent (4 ll) was prepared
and left at room temperature for 45 min. During this time,
the medium was removed from the above-mentioned cells
and the cells were washed once with 2 ml of the
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Transfection Medium containing no serum or antibiotics.
Next, the previously prepared transfection mixture was
added to the cell culture and incubated for 5 h at 37 C.
After this time, 1 ml of growth medium containing serum
and antibiotics at a two-fold higher concentration than nor-
mal was added without removing the transfection mixture
and incubated for the next 24 h at 37 C. After the incuba-
tion, the whole mixture was replaced with fresh normal
growth medium and quercetin and imperatorin were added
to the cells at appropriate concentrations for 24 h. Addi-
tionally negative controls of Transfection Reagent intro-
ductoring siRNA into cells and specific siRNAs blocking the
expression of Hsps in cells were performed. The effective-
ness of the blocking of Hsp27 and Hsp72 gene expression
was assessed by immunoblotting. Three independent
experiments were performed.
Caspase activity assay
HeLa and Hep-2 cells were cultured in 6-well plates at the
density 2 9 105 cells/well and treated with quercetin
(50 lM) and imperatorin (50 lM) administered separately
or simultaneously. For detection of activity of caspase-3, -8,
and -9, a commercially available assay kit SensoLyteAMC
Caspase Substrate Sampler Kit Fluorimetric (AnaSpec) was
used according to the manufacturer’s protocol. The intensity
of fluorescence was measured by a Perkin Elmer 2030
Multilabel Reader VICTORTM 94 at Ex/Em = 354/442 nm.
Each experiment was performed in triplicate.
Statistical analysis
The quantitative data were expressed as the mean ± stan-
dard deviation (SD). All statistical analyses of the data
were performed using one-way ANOVA tests followed by
a Dunett’s multiple comparison test. Differences with
p values of \ 0.05 were considered statistically significant.
Results
The effect of quercetin and imperatorin on cell viability
(MTT assay)
The cytotoxic activity of querectin and imperatorin on the
viability of HeLa and Hep-2 cell was examined in the
presence of different concentrations of both tested com-
pounds applied singly or in various combinations.
Quercetin
The experiments, we conducted confirmed that 48-h incu-
bations with quercetin markedly diminished HeLa and
Hep-2 cell viability in comparison to 24-h incubations
(Fig. 1A, B). Exposure of HeLa cells to the 50 lM con-
centration of flavonoid for 48 h significantly reduced cell
viability to about 60 %, while addition of 100 lM
decreased viability only by 20 % (Fig. 1A). We achieved
similar results in the case of Hep-2 cell line. Treatment of
Hep-2 cells for 48 h with culture medium containing
quercetin resulted in a strong cytotoxic effect inducing
death of 24.6 % cells after incubation with 50 lM of the
drug and 29.1 % after application of 100 lM (Fig. 1B). As
can be seen in Fig. 1A and B the 24-h incubations with the
flavonoid had much weaker effect on HeLa and Hep-2 cell
survival.
Imperatorin
The experiments that we preformed revealed that impera-
torin occurred to be less cytotoxic than quercetin to both
tested cell lines. Figure 1A clearly indicates on significant
reduction of HeLa cell viability to 70.99 % following
administration of 50 lM of imperatorin for 48 h, while
addition of 100 lM reversed this effect. The MTT viability
test revealed no significant effect of imperatorin on HeLa
cell survival during 24-h incubations. Exposure of Hep-2
cells to imperatorin treatment demonstrated a cytotoxic
effect on cell viability generating a statistically significant
percentage of dead cells after both 24 and 48-h incubation
(Fig. 1B). However, only in the case of application of
100 lM of imperatorin for 24 h to the culture medium a
slight increase in Hep-2 cell viability was observed.
Combined treatment with quercetin and imperatorin
To estimate the combined effect of the tested compounds
on HeLa and Hep-2 cell viability, two variants of the
experiment were performed: (1) the cells were pre-incu-
bated with quercetin or imperatorin for 6 or 24 h followed
by administration of the other compound for the next 18 or
24 h, and (2) the cells were treated with both drugs
simultaneously for 24 and 48 h. These incubation variants
were also used in further experiments.
MTT assays revealed that combined treatment with
quercetin and imperatorin had a much stronger cytotoxic
effect reducing cell viability of both HeLa and Hep-2 cell
lines than incubation with single drugs. The 24-h incuba-
tion provoked the greatest decrease in HeLa cell viability
reaching maximum 43.52 % of dead cells after preincu-
bation with quercetin (Fig. 1C). The other combination
variants of 24-h incubations displayed slightly weaker, but
still statistically significant reduction of cell viability. The
inverse relationship was noticed in the case of 48-h incu-
bations. The pretreatment variants resulted in a clear
cytotoxic effect of both drugs on HeLa cells inducing ca.
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20 % of dead cells after pretreatment with quercetin, and
ca. 30 % as a result of pretreatment with imperatorin
(Fig. 1C). However, simultaneous administration of quer-
cetin and imperatorin for 48 h led to progressive reduction
of HeLa cell viability to 52.86 %. As shown in Fig. 1D, the
decrease in Hep-2 cell viability after 24-h incubation was
comparable in all incubation variants and fluctuated around
20–30 % of dead cells. Exposure of the Hep-2 cells to 48-h
treatment of both drugs combination diminished cell via-
bility gradually, consequently inducing 39.34 % of dead
cells after incubation wit quercetin and imperatorin
administered at the same time (Fig. 1D).
Sensitivity of HeLa and Hep-2 cells to quercetin
and imperatorin treatment
Apoptosis, autophagy, and additionally necrosis assays
were performed on the HeLa and Hep-2 cell lines in the
presence of various concentrations of quercetin and impe-
ratorin administered separately or in different combination
variants.
Quercetin
The HeLa and Hep-2 cells were incubated with quercetin at
the concentrations 50 and 100 lM for 24 and 48 h. As can
be seen in Fig. 2A, the 48-h incubation of the HeLa cells
with the flavonoid resulted in effective apoptosis induction
and the highest percentage of apoptotic cells (27.54 %) was
noticed after the treatment with 50 lM of the drug, while
the number of necrotic cells reached about 2.5 %. In turn,
incubation with a 100 lM concentration of quercetin
proved to be less effective and the level of apoptotic cells
fluctuated around 9.5 %. Furthermore, at the same time an
increased level of necrosis was observed (6.06 %). Thus,
the 50 lM concentration of quercetin was chosen for
Fig. 1 The cytotoxic effect of quercetin, imperatorin (A, B) and
combined treatment with both drugs (C, D) on viability of HeLa (A,
C) and Hep-2 (B, D) cells. C control, Q quercetin, I imperatorin,
Q ? I cells pre-incubated with quercetin followed by imperatorin
administration, I ? Q cells pre-incubated with imperatorin followed
by quercetin administration, QI cells treated with both drugs
administered simultaneously; *p \ 0.05
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further experiments. The 24-h incubation with quercetin
was less efficient and initiated apoptosis at a level not
exceeding 9 % (Fig. 2A). Treatment with quercetin at both
concentrations tested and the incubation time did not
stimulate autophagy induction in HeLa cells.
Similar results were obtained in the case of Hep-2 cells.
Quercetin at the 50 lM concentration administered to the
culture medium for 48 h yielded the highest percentage of
apoptotic cells (17.89 %), and the level of necrosis was
compared to the control cells (Fig. 2B). Treatment with
100 lM of the flavonoid stimulated apoptosis at a level not
exceeding 8 %. However, this concentration exerted a
strong cytotoxic effect (9.06 %), and a high percentage of
detached cells was observed. Therefore, the concentration
of 50 lM of quercetin was used for subsequent investiga-
tions. The 24-h incubations with the flavonoid were less
effective, and the level of apoptosis reached only about
8.5 % after the treatment with 50 lM of compound. As can
Fig. 2 The effect of quercetin (A, B), imperatorin (C, D) and
combined treatment with both drugs (E, F) on apoptosis, necrosis, and
autophagy induction in HeLa (A, C, E) and Hep-2 (B, D, F) cell lines.
C control, Q quercetin, I imperatorin, Q ? I cells pre-incubated with
quercetin followed by imperatorin administration; I ? Q cells pre-
incubated with imperatorin followed by quercetin administration, QI
cells treated with both drugs administered simultaneously; *p \ 0.05
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be seen in Fig. 2B, quercetin did not appear to be a potent
autophagy inducer in Hep-2 cells. The percentage of cells
undergoing autophagy was comparable to that in the
control.
Imperatorin
Imperatorin, as well as quercetin, at the 50 lM concen-
tration applied to the culture medium for 48 h appeared to
be a potent apoptosis inducer in HeLa cells initiating
16.52 % of apoptotic cells (Fig. 2C). This was accompa-
nied with a low level of necrosis (2.19 %), comparable to
that found in the control cells. Treatment with 100 lM of
compound had no effect on apoptosis initiation, but an
increased number of necrotic cells was noticed. Thus, the
50 lM concentration was chosen for further experiments.
The 24-h long incubations generated apoptosis less effec-
tively and the level of apoptotic cells reached only 5.99 %
after the treatment with 50 lM of the compound. More-
over, an increasing number of necrotic cells, reaching
6.53 % was observed as a result of incubation with 100 lM
of imperatorin. The incubations indicated that imperatorin,
likewise quercetin, had no significant influence on
autophagy induction in HeLa cells.
Microscopic observations revealed that the treatment
with 50 lM of imperatorin for 48 h induced the highest
percentage of apoptotic cells (8.58 %) in the Hep-2 cell
line (Fig. 2D). Incubation with 100 lM of the compound
provoked less effective initiation of apoptosis (3.93 %),
causing necrosis in 8.14 % of cells. Incubation of Hep-2
cells with both tested concentrations of imperatorin for
24 h stimulated apoptosis at a level similar to that in the
control cells. As can be seen in Fig. 2D, imperatorin was
not a potent autophagy initiator in Hep-2 cells.
Combined quercetin and imperatorin treatment
As shown in Fig. 2E and F, apoptosis induction in both cell
lines was dependent on time and the drug application
procedure. In the case of the HeLa cell line, we observed
that the 48-h incubation proved to be the most effective in
apoptosis induction resulting in maximum 34.89 % of
apoptotic cells after simultaneous administration of quer-
cetin and imperatorin (Fig. 2E). This was accompanied
with a low level of necrotic cells, not exceeding 4 %.
Initiation of apoptosis in HeLa cells pre-incubated with
imperatorin was less effective, reaching 15.96 % of cells,
and the number of necrotic cells was comparable to that in
the control. In turn, pretreatment with quercetin was less
efficient in apoptosis initiation, but the level of apoptotic
cells (9.32 %) was still higher than that observed in the
control. As can be seen in Fig. 2E, the 24-h incubation
resulted in weaker but statistically significant initiation of
apoptosis. The best result was achieved after pretreatment
with quercetin, yielding maximum 28.97 % of apoptotic
cells. Surprisingly, simultaneous administration of both
tested compounds to the HeLa cells culture medium
resulted in unexpectedly low percentage of apoptotic cells
not exceeding 5 %. The combined drug treatment in all the
incubation variants had no effect on autophagy induction in
HeLa cells.
In the case of Hep-2 cell line, the strongest initiation of
apoptosis was noticed also after the 48-h incubation. The
highest level of apoptotic cells reaching 30.13 % was
observed after incubation with quercetin and imperatorin
applied to the culture medium at the same time (Fig. 2F).
This incubation variant also generated a low level of necrotic
cells (3.53 %). The other options of the 48-h treatment ini-
tiated apoptosis less efficiently, but the level of apoptosis was
still significantly higher than that observed in the control
cells. The shorter incubation time appeared to be remarkably
weaker in apoptosis induction (Fig. 2F). The highest per-
centage of apoptotic cells reached only 13.22 % after the
treatment with quercetin and imperatorin administered
simultaneously. Hep-2 cells displayed no sensitivity to
autophagy induction upon the tested compounds.
The effect of quercetin and imperatorin
on the expression of cell death marker proteins
Activity of caspase-3, caspase-8 and caspase-9
The best-studied mediators of apoptosis include caspases,
i.e., aspartate-specific cysteine proteases, which function as
ultimate effectors during apoptosis. Our investigations
carried out on the HeLa cell line revealed a strong increase
in the activity of caspase-3 in all experimental variants
(Fig. 3A). The best results were achieved after the treat-
ment with quercetin and imperatorin applied to the culture
medium simultaneously. This combination of the drugs
caused almost a double increase in caspase-3 activity,
reaching 194.55 %. In turn, the activity of caspase-8
increased only as a result of incubation with imperatorin
(106.6 %). The activation of caspase-9 was observed after
incubation with imperatorin and pretreatment variants.
In the case of the Hep-2 cell line, we observed that
activation of all caspases was significant weaker (Fig. 3B).
Incubation with quercetin and imperatorin applied simul-
taneously revealed the strongest activation of caspase-3,
reaching 147.57 %. The other experimental variants dis-
played less effective level of caspase-3 activity, but still
significant. As shown in Fig. 3B, only incubation with
quercetin resulted in activation of caspase-8 (113.9 %).
The activation of caspase-9 increased only after the treat-
ment with both drugs administered simultaneously
(115.06 %).
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Fig. 3 The effect of quercetin (50 lM) and imperatorin (50 lM)
administered separately or simultaneously on the activation of
caspases (A, B), expression of beclin-1 (C, D), Hsp27 (E, G), and
Hsp72 (F, H) in HeLa (A, C, E, F) and Hep-2 (B, D, G, H) cell lines.
C control, Q quercetin, I imperatorin, Q ? I cells pre-incubated with
quercetin followed by imperatorin administration; I ? Q cells pre-
incubated with imperatorin followed by quercetin administration, QI
cells treated with both drugs administered simultaneously. Represen-
tative western blots are included; *p \ 0.05
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Estimation of beclin-1expression
Beclin-1, one of the Bcl-2 family members, is one of the
best-studied autophagy mediators. This protein recruits
numerous key autophagic proteins required for proper
initiation of autophagosome formation. Cell staining with
acridine orange revealed that quercetin and imperatorin
turned out not to be potent autophagy inducers in HeLa and
Hep-2 cells. These results were further confirmed by
molecular analysis, which showed that neither of the tested
compounds administered separately or in combination had
the ability to initiate autophagy in HeLa (Fig. 3C) and
Hep-2 (Fig. 3D) cells.
Expression of Hsp27 and Hsp72 proteins
The expression of Hsp27 in HeLa cells was dependent on
the drug application procedure. Incubation of HeLa cells
with quercetin and imperatorin in all experimental variants
displayed differences in the expression of Hsp27, however,
they were not statistically significant (Fig. 3E). Surpris-
ingly, in the case of Hsp72 expression, we observed an
inhibitory effect of the tested compounds in all the exper-
imental options (Fig. 3F). Quercetin and imperatorin
administered simultaneously resulted in the strongest
reduction in the level of the Hsp72 reaching over 50 %.
The experiments conducted on the Hep-2 cell line
revealed that both drugs exerted a strong inhibitory effect
on Hsp27 expression, but only as a result of simultaneous
administration to the culture medium (Fig. 3G). This drug
combination resulted in a decrease in the level of Hsp27 to
69.96 %. Our experiments also demonstrated that both
drugs applied separately as well as in combinations lead to
a potent reduction of the Hsp72 level. As can be seen in
Fig. 3H, the treatment with quercetin and imperatorin
given at the same time proved to be the most powerful
variant yielding almost two-fold lower expression of Hsp72
(55.55 %).
Effects of quercetin and imperatorin on the Hsp27
and Hsp72 expression in transfected HeLa and Hep-2
cells
The efficiency of blocking the expression of Hsp27 and
Hsp72 genes with specific siRNA was examined by
immunoblotting analysis. Our experiments demonstrated
that transfection of HeLa and Hep-2 cells proved to be
successful and remarkably diminished the level of Hsp27
and Hsp72 expression. Transfected HeLa cells showed a
marked reduction of the Hsp27 level after the treatment
with quercetin and imperatorin administered simulta-
neously, which reduced the protein expression to 19.3 %
(Fig. 4A). Both drugs applied at the same time also
appeared to be the most efficient combination inhibiting the
expression of Hsp72 to 22.45 % (Fig. 4B). Although
administration of quercetin and imperatorin separately
resulted in a slight increase in the expression of both pro-
teins in transfected HeLa cells, the levels of Hsp27 and
Hsp72 were still strongly reduced by over 60 %.
Similar results were achieved in the case of transfected
Hep-2 cells. Our experiments demonstrated that the most
effective reduction of Hsp27 and Hsp72 level was noticed
after the simultaneous treatment with quercetin and impe-
ratorin. The expression of Hsp27 was reduced to 28.53 %
(Fig. 4C), while Hsp72 expression reached only 21.09 %
(Fig. 4D), respectively. Despite blocking the genes of
Hsp27 and Hsp72 expression, a minor increase in their
level after incubation with the drugs applied separately was
observed. However, the expression of both proteins was
still strongly diminished by more than 50 %.
Sensitivity of transfected cells on apoptosis, autophagy,
and necrosis induction upon quercetin and imperatorin
The transfected HeLa and Hep-2 cells were exposed to
quercetin and/or imperatorin treatment. The experiments
conducted revealed that the silencing of Hsp27 and Hsp72
gene expression was strictly correlated with the increased
sensitivity of HeLa (Fig. 5A, B) and Hep-2 (Fig. 5C, D)
cells to apoptosis induction by the tested drugs. It should be
noted that blocking of the gene expression of Hsp27 and
Hsp72 in both cell lines caused such strong sensitization of
cancer cells that extending the incubation time to 48 h
resulted in a strong cytotoxic effect. We observed extre-
mely sparse cell cultures and a high percentage of detached
cells (data not shown).
Morphological analysis performed after the 24-h incu-
bation of HeLa cells with diminished Hsp27 and with
diminished Hsp72 expression revealed effective induction
of apoptosis, especially after the simultaneous treatment
with quercetin and imperatorin (Fig. 5A, B). The other
incubation variants resulted in a lower percentage of dead
cells, but still higher that than observed in the control. No
significant effects in necrosis induction were observed.
Furthermore, downregulation of Hsp27 and Hsp72 gene
expression had no impact on autophagy induction in the
HeLa cells.
Microscopic observations after the 24-h incubation of
Hep-2 cells with decreased expression of Hsp27 and Hsp72
demonstrated an increased number of apoptotic cells
especially after the treatment with quercetin and impera-
torin administered at the same time (Fig. 5C, D). The other
experimental variants were less effective in apoptosis
induction, but still the results were significant. Silencing of
the Hsp27 and Hsp72 gene expression in Hep-2 cells had
no effect on necrosis induction or initiation of autophagy.
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Additional experiments with negative controls of
Transfection Reagent and siRNAs that we performed
demonstrated no effect of these factors on cell death
induction.
Discussion
Elimination of cancer cells from human organism is a real
challenge for scientists all over the world. The complexity
of the nature of cancer cells still makes it the focus of
attention of many researches. A body of literature describes
cancer cells characterized by altered metabolism, pH
imbalances, hypoxia, and relatively undamaged DNA
synthesis checkpoints leading to heavy mutation load.
Additionally, cancer cells often overexpress Hsps, probably
because of the stressful conditions in which tumors reside,
but also because of the benefits of Hsps cytoprotection [33,
34]. Recently, more attention has been paid to the phe-
nomenon of Hsp overexpression in cancer cells, among
which Hsp27 and Hsp72 have been attached a great deal of
importance as apoptotic chaperone proteins. Therefore,
these proteins are one of the key elements blocking the
programmed cell death induction, consequently leading to
the reduction of cancer cells sensitivity to commonly used
chemotherapy [14].
In the past years, quercetin has appeared as a potential
therapeutic agent for treatment of various types of cancers
due to its ability of apoptosis induction. The proapoptotic
activity of quercetin against cancer cells has been well
documented, e.g., in leukemia (HL-60) [35], osteosarcoma
(MG-63) [36], colon (LoVo) [37], breast (MCF-7, U937)
[37–39], brain (MOGGCCM, T98G) [40–42], and lung
(NCI-H209) [43] cell lines. Since quercetin has been
examined in a variety of cancer cells, it is important to
understand the effect of the flavonoid also on normal, non-
Fig. 4 The expression of Hsp27 (A, C), Hsp72 (B, D) in transfected
HeLa (A, B) and Hep-2 (C, D) cell lines subsequently treated with
quercetin (50 lM) and imperatorin (50 lM) for 24 h. C control; TR
HeLa/Hep-2 cells incubated only with Transfection Reagent (TR)
introductoring siRNA into cells; si27/si72 HeLa/Hep-2 cells incu-
bated only with specific siRNA blocking the expression of Hsp27 or
Hsp72 in cells; TRsi27/TRsi72 HeLa/Hep-2 cells incubated with
complex of TR and specific siRNA which blocks the expression of
Hsp27 or Hsp72 in cells; Q quercetin; I imperatorin; QI drugs
administered simultaneously. Representative western blots are
included; *p \ 0.05
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malignant cells. Several lines of evidence indicates that
quercetin exerts a selective cytotoxic effect on both normal
and transformed cells. Studies conducted on non-malignant
cells such as neurons [44], mouse thymocytes [45], and
bone marrow cells [46] proved the beneficial cytoprotec-
tive effects of quercetin associated with free radicals
scavenging and modulating the biochemical markers of
oxidative stress and antioxidant enzymes [47, 48].
Several reports have proposed the mechanisms involved
in the proapoptotic properties of this flavonoid consisting in
activation of kinases, downregulation of survival pathways,
mitochondrial potential perturbation, release of cytochrome
c, and, in consequence, activation of caspase-3 and caspase-9
[18, 22, 35, 36, 38]. Experiments have shown that micro-
molar concentrations of quercetin in the range of
29–150 lmol/l can induce apoptosis. It has also been
reported that quercetin has an effective ability to inhibit Hsps
synthesis. Literature data suggest that it blocks the expres-
sion of Hsp27 and Hsp72 at the transcriptional level by
preventing binding of heat shock factor 1 and 2 (Hsf1, Hsf2)
to the conserved DNA sequence called the heat shock ele-
ment (HSE). Another theory assumes that quercetin blocks
additional modifications needed to activate Hsf, such as post-
translational phosphorylation [17, 21].
Assessing cell death has become an indispensable part
of biological research, with novel unique technologies
being released at a rapid rate. One of the measurement with
a long-held reputation as the conventional cell proliferation
assay is MTT, a simply preliminary test, used for mea-
suring cell viability and proliferation of living cells and
evaluation of the cytotoxicity and effectiveness of a
potential drug candidate. MTT test, supported by a strong
body of literature, is a metabolic activity assay which
involves the use of tetrazolium salt cleaved in the mito-
chondria of metabolically active cells to colored formazan
salt that can be measured by absorbance. The amount of
formazan dye produced is directly proportional to the
quantity of metabolically active cells [49–51].
The present study indicates quercetin as an effective
antiproliferative drug. The experiment that we performed
Fig. 5 The level of apoptosis, necrosis, and autophagy induction in
HeLa (A, B) and Hep-2 (C, D) cells after blocking the Hsp27 (A,
C) and Hsp72 (B, D) expression subsequently treated with quercetin
(50 lM) and imperatorin (50 lM) for 24 h. C control; TR HeLa/Hep-
2 cells incubated only with Transfection Reagent (TR) introductoring
siRNA into cells; si27/si72 HeLa/Hep-2 cells incubated only with
specific siRNA blocking the expression of Hsp27 or Hsp72 in cells;
TRsi27/TRsi72 HeLa/Hep-2 cells incubated with complex of TR and
specific siRNA which blocks the expression of Hsp27 or Hsp72 in
cells; Q quercetin; I imperatorin; QI drugs administered simulta-
neously; *p \ 0.05
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demonstrated a significant reduction of the viability of both
cell lines studied especially after 48 h of treatment with
50 lM of quercetin yielding 37.97 % of dead cells in the
case of the HeLa cell line and 29.1 % in the case of the
Hep-2 cell line.
Since the MTT test revealed cell death in both tested cell
lines, we used a staining method with specific fluoro-
chromes to determine the types of cell death. Induction of
apoptosis and necrosis in HeLa and Hep-2 cells upon
quercetin treatment was assayed by simultaneous use of the
double Hoechst 33342/PI staining method. This convenient
and rapid measurement is commonly used to distinguish
normal, apoptotic, and necrotic cells. The blue fluorescent
DNA stain Hoechst is a cell permeable nucleic acid that
binds within the minor groove of double-stranded AT-rich
regions in DNA. Thus, it allows to identify chromatin
condensation and fragmentation by staining the condensed
nuclei of apoptotic cells. In turn, the red-fluorescent PI is a
cell impairment DNA dye, which only penetrates the cells
with the lost cellular membrane integrity [52, 53].
The morphological analysis, we performed and con-
firmed that quercetin was an effective apoptosis inducer in
HeLa and Hep-2 cells at the 50 lM concentration after
48 h of the treatment, yielding the maximum percentage of
dead cells 25.54 % in the HeLa cell line and 17.89 % in the
case of the Hep-2 cell line, respectively. At the molecular
level, the apoptosis induction in the HeLa and Hep-2 cells
was closely correlated with the expression of Hsp27 and
Hsp72 protein, well-known apoptosis inhibitors. Our
experiments demonstrated an effective inhibitory effect of
the flavonoid on Hsp72 expression in both cell lines stud-
ied, resulting in sensitizing HeLa and Hep-2 cells to
apoptosis initiation. These results corresponded with an
increased activity of caspase-3 in both cell lines and cas-
pase-8 only in Hep-2 cells after the quercetin treatment.
Based on these results, it can be suggested that the pathway
of the apoptotic signal depended on the cell line. Further-
more, we can hypothesize that apoptosis induced by the
flavonoid may proceed not only through the mitochondrial
pathway.
Several articles have reported that quercetin has the
ability to trigger autophagy in cancer cells [54]. Paradox-
ically, the morphological analysis carried out revealed that
the flavonoid was a weak autophagy inducer in both HeLa
and Hep-2 cell lines. These results were further verified at
the molecular level by measurement of the beclin-1 level,
which showed no significant changes in its expression.
Thus, quercetin has no ability to induce autophagy in HeLa
and Hep-2 cells.
An increasing number of reports has described impera-
torin as a compound with potent anticancer properties
manifested in inhibition of cell proliferation and induction
of apoptosis in several types of cancer, i.e., hepatoma
(HepG2) [55] and leukemia (HL-60) [56]. The results of
various biochemical analysis revealed the ability of impe-
ratorin to arrest cell cycle and trigger apoptosis via both
death receptor and mitochondria mediated pathways.
However, the underlying mechanism of this proapoptotic
activity is not yet fully understood [23, 27, 55, 56]. Despite
the fact that imperatorin, widely used in ethnomedicine for
many centuries, has been the subject of intensive research
for only a few years, there is still no literature data indi-
cating toxicity of imperatorin to normal cells.
Our experiments on HeLa and Hep-2 cell lines demon-
strated that imperatorin likewise quercetin exerted strong
antiproliferative effect markedly diminishing viability of
both cell lines and inducing 29.01 % of dead HeLa cells
and 13.5 % of dead Hep-2 cells after 48-h treatment with
the 50 lM concentration. The validity of the results men-
tioned above was further corroborated by morphological
analysis which clearly indicated on imperatorin as an
effective apoptosis initiator resulting in maximum 16.52 %
of dead cells in the case of HeLa cells and 8.58 % in the
case of Hep-2 cells after treatment with 50 lM for 48 h. At
the molecular level, this was accompanied with the effi-
cient inhibition of the expression of Hsp72 in both cell
lines, which made the cells more sensitive to apoptosis
induction. Although currently there is very little under-
standing about a possible mechanism of Hsp inhibition by
imperatorin, our experiments suggest imperatorin as a
possible suppressor of Hsp expression. Induction of apop-
tosis in HeLa and Hep-2 cells upon the imperatorin treat-
ment was additionally confirmed by measurements of
caspase activity, which revealed an increasing activity all
of the tested caspases in HeLa cells and only caspase-3 in
the Hep-2 cell line. These results allow a hypothesis that
imperatorin induces apoptosis in HeLa and Hep-2 cells via
the mitochondrial and death receptor pathway. On the other
hand, imperatorin turned out not to be a potent autophagy
inducer in HeLa and Hep-2 cells. Microscopic analysis, as
well as measurement of the beclin-1 expression gave no
support to challenge this hypothesis.
It is well documented that natural plant extracts and
natural compounds exhibit a synergistic anti-tumor effect
[57]. Herein, we decided to examine, for the first time, the
effect of the combined treatment of quercetin and impe-
ratorin on cell death induction in HeLa and Hep-2 cells.
We measured cell death induction in cells pretreated with
quercetin or imperatorin followed by imperatorin or quer-
cetin administration and with both compounds applied
simultaneously. It is worth noting the different kinetics of
action of quercetin and imperatorin in the tested cell lines
dependent on time and the drug application procedure. Our
experiments demonstrated that the combination of both
drugs applied at the same time for 48 h was the most
effective in inhibiting of proliferation generating 47.14 %
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of dead HeLa cells and 39.34 % of dead Hep-2 cells.
Verification obtained results by morphological analysis
confirmed that simultaneously administration of both drugs
tested were the most genuine and powerful drug combi-
nation in apoptosis induction, reaching maximum 34.89 %
of dead cells in the case of the HeLa cells and 30.13 % in
the case of the Hep-2 cell line. Surprising seemed to be a
very low level of apoptotic HeLa cells induced as a result
of 24 h treatment with both drugs applied at the same time.
This can be explained by unspecific reaction of HeLa cells
that caused the detachment of cells from the substrate and
prevented precise morphological analysis.
Obtained results were consistent at the molecular level
with the strongest inhibition of Hsp27 and Hsp72 expres-
sion and the intense activation of caspase-3 in both cell
lines. The combined treatment with quercetin and impe-
ratorin also contributed to activation of caspase-9 in HeLa
and Hep-2 cells. These findings may suggest synergistic
action of quercetin and imperatorin, which makes them a
novel effective couple inducing apoptosis. Neither drug at
all the combination variants had a significant effect on
autophagy induction in both cell lines.
Numerous studies indicate that the unusual expression
of Hsp27 and Hsp72 is crucial for progression of different
types of human cancer and is closely associated with
resistance to apoptosis by enhancement of cell growth. It
has been reported that Hsp27 and Hsp72 can regulate
apoptosis through their ability to interact with the key
elements of the apoptotic-signaling pathways. However,
the mechanism by which this is achieved still remains
unclear. Nevertheless, it is known that overexpression of
Hsp27 and Hsp72 in tumor cells negatively regulates
apoptosis by preventing recruitment of procaspase-9 and
procaspase-3 and sequestration of cytostolic cytochrome
c from Apaf-1 after its release from the mitochondrion,
thereby preventing the assembly of the functional apopto-
some. Indirect experimental evidence suggests that down-
regulation of Hsps expression in cancer cells may either
sensitize them to chemotherapy or commit to apoptosis [15,
57–65]. Thus, to obtain direct evidence of the participation
of Hsp27 and Hsp72 in resistance to apoptosis of the cancer
cells studied, silencing of the Hsp27 and Hsp72 gene
expression by specific siRNA was performed. Our experi-
ments at the molecular level demonstrated that the trans-
fection of HeLa and Hep-2 cells occurred to be successful
and resulted in marked reduction of the Hsp27 and Hsp72
level in both cell lines, consequently sensitizing HeLa and
Hep-2 cells to apoptosis induction. Downregulation of the
Hsp27 and Hsp72 expression in HeLa and Hep-2 cells, and
further treatment with the tested drugs resulted in an
increasing percentage of apoptotic cells. Once again, the
combined drug treatment proved to be more efficient in
apoptosis induction in both transfected cell lines than
application of single agents. Nevertheless, the results
mentioned were not as high as those observed in non-
transfected cells. The intriguing blocking of Hsp27 and
Hsp72 gene expression still had no effect on autophagy
induction upon the quercetin and imperatorin treatment.
Conclusion
In the present study, we have provided evidence supporting
the potential of quercetin and imperatorin as effective
anticancer compounds inhibiting proliferation and inducing
apoptosis in HeLa and Hep-2 cell lines. Herein, we have
also demonstrated for the first time that the combined
treatment with quercetin and imperatorin administered
simultaneously greatly induced growth inhibition in cancer
cell and consequently bringing them to apoptotic pathways.
Furthermore, we have reported that silencing of Hsp27 and
Hsp72 gene expression in HeLa and Hep-2 cells had no
significant effect on sensitizing both cell lines on apoptosis
induction in comparison to non-transfected cells. This
might be explained by incomplete Hsp inhibition addi-
tionally hindered by quercetin and imperatorin. Neverthe-
less, our findings illustrate the potential use of combination
quercetin with imperatorin as an effective, novel tool to
eliminate various types of cancer. However, further studies
are needed to elucidate the precise nature of this
phenomenon.
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